Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2013

12, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, "Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2013" provides data on the Inflammatory Bowel Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inflammatory Bowel Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inflammatory Bowel Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Table of Contents Clinical Trials by Region 8 Clinical Trials by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Countries Contributing to Clinical Trials in Central and South America 15 Clinical Trials by BRIC Nations 16 Clinical Trials by G7 Nations 17 Clinical Trials in G7 Nations by Trial Status 18 Clinical Trials by E7 Nations 19 Clinical Trials in E7 Nations by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Unaccomplished Trials of Inflammatory Bowel Disease 24 Subjects Recruited Over a Period of Time 32 Prominent Sponsors 33 Top Companies Participating in Inflammatory Bowel Disease Therapeutics Clinical Trials 35 Prominent Drug Comparison 37 Clinical Trial Overview of Top Companies 38 AbbVie Inc. 38 Clinical Trial Overview of AbbVie Inc. 38 UCB S.A. 40 Clinical Trial Overview of UCB S.A. 40 Pfizer Inc. 42 Clinical Trial Overview of Pfizer Inc. 42 GlaxoSmithKline plc 43 Clinical Trial Overview of GlaxoSmithKline plc 43 Merck & Co., Inc. 44 Clinical Trial Overview of Merck & Co., Inc. browse around these guys http://www.bizjournals.com/prnewswire/press_releases/2013/09/12/BR78716